[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2038678T3 - Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos. - Google Patents

Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.

Info

Publication number
ES2038678T3
ES2038678T3 ES198787311321T ES87311321T ES2038678T3 ES 2038678 T3 ES2038678 T3 ES 2038678T3 ES 198787311321 T ES198787311321 T ES 198787311321T ES 87311321 T ES87311321 T ES 87311321T ES 2038678 T3 ES2038678 T3 ES 2038678T3
Authority
ES
Spain
Prior art keywords
hydrogen
alkyl
nr6r7
hydroxy
alcoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787311321T
Other languages
English (en)
Inventor
Roger Edward Markwell
Stephen Allen Smith
Ian Hughes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630928A external-priority patent/GB8630928D0/en
Priority claimed from GB878717924A external-priority patent/GB8717924D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of ES2038678T3 publication Critical patent/ES2038678T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBEN NUEVOS COMPUESTOS DE FORMULA (I), PROCEDIMIENTOS PARA SU OBTENCION Y SU USO COMO INHIBIDORES DE COLAGENASA, FORMULA EN LA QUE R1 ES HIDROXI; ALCOXI; ARILOXI; ARALQUILOXI; -NR6R7, DONDE R6 Y R7 SON HIDROGENO O ALQUILO, O R6 Y R7 JUNTO CON EL ATOMO DE NITROGENO AL CUAL STAN UNIDOS FORMAN UN ANILLO DE 5-7 MIEMBROS CON UN HETEROATOMO OPCIONAL; -NHCH(R8)COR9 DONDE R8 ES HIDROGENO, ALQUILO, OPCIONALMENTE SUSTITUIDO POR HIDROXI, ALCOXI, -NR6R7, GUANIDINA, CO2H, CONH2, SH O S-ALQUILO; O CH2-AR DONDE AR ES ARILO OPCIONALMENTE SUSTITUIDO; Y R9 ES HIDROXI, ALCOXI O -NR6R7. R2 ES HIDROGENO O ACILO. R3 ES ALQUILO C3-C6. R4 ES HIDROGENO; ALQUILO; -CH2R10 DONDE R10 ES FENILO O HETEROARILO OPCIONALMENTE SUSTITUIDO; O -CH(R12)O-R11 DONDE R11 ES HIDROGENO; ALQUILO, O -CH2PH DONDE PH ES FENILO OPCIONALMENTE SUSTITUIDO; Y R12 ES HIDROGENO O ALQUILO. R5 ES HIDROGENO; ALQUILO; O -CH(R13)COR14 DONDE R13 ES HIDROGENO O ALQUILO; Y R14 ES HIDROXI, ALCOXI O -NR6R7.
ES198787311321T 1986-12-24 1987-12-22 Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos. Expired - Lifetime ES2038678T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630928A GB8630928D0 (en) 1986-12-24 1986-12-24 Compounds
GB878717924A GB8717924D0 (en) 1987-07-29 1987-07-29 Compounds

Publications (1)

Publication Number Publication Date
ES2038678T3 true ES2038678T3 (es) 1993-08-01

Family

ID=26291743

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787311321T Expired - Lifetime ES2038678T3 (es) 1986-12-24 1987-12-22 Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.

Country Status (12)

Country Link
US (2) US4937243A (es)
EP (1) EP0273689B1 (es)
KR (1) KR880007451A (es)
AU (1) AU599736B2 (es)
CA (1) CA1322073C (es)
DE (1) DE3774858D1 (es)
DK (1) DK681287A (es)
ES (1) ES2038678T3 (es)
GR (1) GR3003761T3 (es)
IE (1) IE60751B1 (es)
NZ (1) NZ223037A (es)
PT (1) PT86433B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729804D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
GB8814813D0 (en) * 1988-06-22 1988-07-27 Beecham Group Plc Novel compounds
WO1990005141A1 (en) * 1988-11-10 1990-05-17 Australian Commercial Research & Development Limited Amino acid and peptide inhibitors of human leukocytic elastase and collagenase
GB9000846D0 (en) * 1990-01-15 1990-03-14 Beecham Group Plc Novel compounds
GB9022117D0 (en) * 1990-10-11 1990-11-21 Beecham Group Plc Novel compounds
US5187305A (en) * 1990-11-26 1993-02-16 Glaxo Inc. S-nitroso-N-alkonoylpenicillamines
GB9107367D0 (en) * 1991-04-08 1991-05-22 Smithkline Beecham Plc Novel compounds
AU3475393A (en) * 1992-01-15 1993-08-03 Merck & Co., Inc. Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
EP1002556A3 (en) * 1992-05-01 2001-01-10 British Biotech Pharmaceuticals Limited Use of MMP inhibitors
GB9211707D0 (en) * 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
AU5292193A (en) * 1992-10-02 1994-04-26 Merck & Co., Inc. N-(mercaptoacyl)peptidyl derivatives as antidegenerative agents
US6090785A (en) * 1992-10-15 2000-07-18 Merck & Co., Inc. Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative agents
WO1994012169A1 (en) * 1992-11-25 1994-06-09 Merck & Co., Inc. Carboxy-peptidyl derivatives as antidegenerative active agents
GB9323165D0 (en) * 1993-11-10 1994-01-05 Chiros Ltd Compounds
US5831004A (en) * 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
AR002945A1 (es) * 1994-11-15 1998-05-27 Bayer Corp Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de matriz, composicion que los contiene, y metodos para la preparacion de dichos compuestos
WO1996035687A1 (en) * 1995-05-10 1996-11-14 Chiroscience Limited Peptidyl compounds and their therapeutic use
WO1996035714A1 (en) * 1995-05-10 1996-11-14 Chiroscience Limited Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
US5932579A (en) * 1996-06-18 1999-08-03 Affymax Technologies N.V. Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH628247A5 (en) * 1975-01-03 1982-02-26 Ciba Geigy Ag Aqueous, film-forming concentrates for extinguishing or preventing fire with a content of non-anionic compounds containing perfluoroalkylalkylenethio groups
US4263293A (en) * 1980-05-30 1981-04-21 E. R. Squibb & Sons, Inc. Heterocyclic containing amides as inhibitors of mammalian collagenase
US4410543A (en) * 1981-03-26 1983-10-18 Ciba-Geigy Corporation Carboxylated oxime-carbamates and their use in controlling pests
EP0136883B1 (en) * 1983-10-03 1987-11-25 E.R. Squibb & Sons, Inc. Enkephalinase inhibitors
US4595700A (en) * 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors

Also Published As

Publication number Publication date
PT86433A (en) 1988-01-01
AU599736B2 (en) 1990-07-26
DK681287D0 (da) 1987-12-22
CA1322073C (en) 1993-09-07
IE873505L (en) 1988-06-24
EP0273689A2 (en) 1988-07-06
EP0273689B1 (en) 1991-11-27
GR3003761T3 (es) 1993-03-16
DE3774858D1 (de) 1992-01-09
NZ223037A (en) 1991-04-26
EP0273689A3 (en) 1989-07-12
AU8292687A (en) 1988-09-01
US5109000A (en) 1992-04-28
US4937243A (en) 1990-06-26
PT86433B (pt) 1990-11-20
DK681287A (da) 1988-06-25
IE60751B1 (en) 1994-08-10
KR880007451A (ko) 1988-08-27

Similar Documents

Publication Publication Date Title
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
AR055878A1 (es) Derivados de ciclopropanocarboxamida
ES2070175T3 (es) Derivados de acido 4-oxoquinolino-3-carboxilico, su preparacion y su uso.
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
CO5640117A2 (es) Derivados de 2,4-diamonopirimidina
AR018917A1 (es) Compuestos derivados de adenosina que son agonistas en el receptor adenosina a1, proceso para su preparacion, composiciones farmaceuticas que los contienen.
PE20010211A1 (es) Compuestos de tiazol y composiciones farmaceuticas para inhibir las quinasas de proteina
ES2033423T3 (es) Procedimientos para preparar derivados de 2-fenilpurinona.
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
HUP9802865A2 (hu) N-(szubsztituált fenil-)-pirazol-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó parazitaellenes készítmények
AR037907A1 (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
MX9307654A (es) Derivados de amina, proceso para su preparacion y composicion farmaceutica que los contiene.
CO5601021A2 (es) Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb
PT1064281E (pt) Derivados de distamicina benzo-heterociclicos processo para os preparar e a sua utilizacao como agentes antitumorais
ES2036213T3 (es) Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos.
AR246962A1 (es) Procedimiento para preparar derivados alquilamino-alquilenicos de ciertos 2h-1-benzopiranos.
AR012157A1 (es) Derivados de piridina, composiciones farmaceuticas que los contienen y procedimiento para la preparacion de dichos derivados.
SE7501365L (es)
MX9301045A (es) Procedimiento para preparar antagonistas receptores de fibrinogeno.
DK304289A (da) Benzenderivater
ES552572A0 (es) Un procedimiento para la preparacion de derivados de beta-lactama.
ES2058064T3 (es) Derivados de beta-carbolina sustituidos con fenoxi, su preparacion y su utilizacion como medicamentos.
ES2055115T3 (es) Derivados de fenil-amidina y fenil-guanidina sustituidos en posicion orto y agentes antidiabeticos y hipoglicemicos que los contienen.
ES2054811T3 (es) Derivados de tetrahidroisoquinolin-2-ilo como antagonistas de tromboxano a2.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 273689

Country of ref document: ES